glipalamide has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berliński, E; Horoszek-Maziarz, S; Jaromczyk-Slisz, J; Krupa-Wojciechowska, B; Orłowska-Kunikowska, E; Rachoń, K; Słomiński, M; Wójcikowski, C | 1 |
1 trial(s) available for glipalamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation].
Topics: Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1985 |